289 related articles for article (PubMed ID: 32159729)
1. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
2. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
3. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
Ju HJ; Han JH; Kim MS; Lee SH; Shin JW; Choi M; Jeong KH; Han TY; Choi CW; Lee HJ; Oh SH; Lee SH; Kim DH; Shin J; Lee JH; Kim SS; Kang HY; Chang SE; Kim JS; Lee DY; Choi GS; Suh DH; Chan Kim Y; Park CJ; Kim KH; Lee AY; Chan Park K; Lee MH; Bae JM;
J Am Acad Dermatol; 2021 Jun; 84(6):1619-1627. PubMed ID: 33508387
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study.
Ko MJ; Tsai WC; Tsai PH; Hsu LY; Chien KL; Wu HY
J Am Acad Dermatol; 2023 Sep; 89(3):496-503. PubMed ID: 37236426
[TBL] [Abstract][Full Text] [Related]
5. Phototherapy for Vitiligo: A Systematic Review and Meta-analysis.
Bae JM; Jung HM; Hong BY; Lee JH; Choi WJ; Lee JH; Kim GM
JAMA Dermatol; 2017 Jul; 153(7):666-674. PubMed ID: 28355423
[TBL] [Abstract][Full Text] [Related]
6. Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis.
Wu YH; Chou CL; Chang HC
Clin Exp Dermatol; 2022 Apr; 47(4):692-699. PubMed ID: 34762747
[TBL] [Abstract][Full Text] [Related]
7. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial.
Zabolinejad N; Maleki M; Salehi M; Ashrafi Z; Molkara S; Layegh P
Australas J Dermatol; 2020 Feb; 61(1):e65-e69. PubMed ID: 31651037
[TBL] [Abstract][Full Text] [Related]
8. Both cardiovascular and cerebrovascular events are decreased following long-term narrowband ultraviolet B phototherapy in patients with vitiligo: a propensity score matching analysis.
Bae JM; Kim YS; Choo EH; Kim MY; Lee JY; Kim HO; Park YM
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):222-229. PubMed ID: 32702138
[TBL] [Abstract][Full Text] [Related]
9. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
Jo SJ; Kwon HH; Choi MR; Youn JI
Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
[TBL] [Abstract][Full Text] [Related]
10. The impact of positive antinuclear antibody on narrowband ultraviolet B phototherapy in patients with vitiligo: A retrospective chart review.
Nahhas AF; Nartker NT; Braunberger TL; Jacobsen G; Hamzavi IH
Photodermatol Photoimmunol Photomed; 2019 Mar; 35(2):106-109. PubMed ID: 30267591
[TBL] [Abstract][Full Text] [Related]
11. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
Natta R; Somsak T; Wisuttida T; Laor L
J Am Acad Dermatol; 2003 Sep; 49(3):473-6. PubMed ID: 12963911
[TBL] [Abstract][Full Text] [Related]
12. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
13. Predictive Model for Response Rate to Narrowband Ultraviolet B Phototherapy in Vitiligo: A Retrospective Cohort Study of 579 Patients.
Cabrera R; Hojman L; Recule F; Sepulveda R; Delgado I
Acta Derm Venereol; 2018 Apr; 98(4):416-420. PubMed ID: 29362810
[TBL] [Abstract][Full Text] [Related]
14. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo.
Mohammad TF; Al-Jamal M; Hamzavi IH; Harris JE; Leone G; Cabrera R; Lim HW; Pandya AG; Esmat SM
J Am Acad Dermatol; 2017 May; 76(5):879-888. PubMed ID: 28216034
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial.
Charoenpongpun N; Kamanamool N; Udompataikul M; Khunkhet S; Kanokrungsee S
Dermatol Ther; 2022 Aug; 35(8):e15596. PubMed ID: 35608017
[TBL] [Abstract][Full Text] [Related]
16. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
[TBL] [Abstract][Full Text] [Related]
17. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
Bansal S; Sahoo B; Garg V
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
[TBL] [Abstract][Full Text] [Related]
18. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
[TBL] [Abstract][Full Text] [Related]
19. Tacalcitol: a useful adjunct to narrow-band ultraviolet-B phototherapy in vitiligo.
Sahu P; Jain VK; Aggarwal K; Kaur S; Dayal S
Photodermatol Photoimmunol Photomed; 2016 Sep; 32(5-6):262-268. PubMed ID: 27552149
[TBL] [Abstract][Full Text] [Related]
20. Influence of Narrow-Band Ultra Violet B Phototherapy on Homocysteine Status: A Prospective Study of Patients with Different Cutaneous Disorders.
Aryanian Z; Shojaee N; Goodarzi A; Shirzadian A; Hatami P
Photobiomodul Photomed Laser Surg; 2021 Sep; 39(9):607-611. PubMed ID: 34546111
[No Abstract] [Full Text] [Related]
[Next] [New Search]